Bio-Techne Corporation is an American
life sciences
This list of life sciences comprises the branches of science that involve the scientific study of life – such as microorganisms, plants, and animals including human beings. This science is one of the two major branches of natural science, ...
company that develops, manufactures and sells
life science
Life, also known as biota, refers to matter that has biological processes, such as signaling and self-sustaining processes. It is defined descriptively by the capacity for homeostasis, organisation, metabolism, growth, adaptation, respon ...
reagent
In chemistry, a reagent ( ) or analytical reagent is a substance or compound added to a system to cause a chemical reaction, or test if one occurs. The terms ''reactant'' and ''reagent'' are often used interchangeably, but reactant specifies a ...
s, instruments and services for the research,
diagnostic
Diagnosis (: diagnoses) is the identification of the nature and cause of a certain phenomenon. Diagnosis is used in a lot of different academic discipline, disciplines, with variations in the use of logic, analytics, and experience, to determine " ...
, and
bioprocessing markets.
[
]
History
The company was founded in 1976 by Roger C. Lucas as Research and Diagnostic Systems, Inc. In 1985, it merged into Techne Corporation and became a public company
A public company is a company whose ownership is organized via shares of share capital, stock which are intended to be freely traded on a stock exchange or in over-the-counter (finance), over-the-counter markets. A public (publicly traded) co ...
.[
In March 2013, Charles (Chuck) Kummeth was named ]chief executive officer
A chief executive officer (CEO), also known as a chief executive or managing director, is the top-ranking corporate officer charged with the management of an organization, usually a company or a nonprofit organization.
CEOs find roles in variou ...
of the company.
In July 2013, the company acquired Bionostics for $104 million.
In February 2014, the company changed its name to Bio-Techne.
In April 2014, the company agreed to acquire Shanghai PrimeGene Bio-Tech Company (PrimeGene).
In July 2014, the company acquired Novus Biologicals for $60 million.
In August 2014, the company acquired ProteinSimple for $300 million.
In November 2014, the company agreed to acquire CyVek for $60 million plus up to an additional $135 million in earn-out payments.
In June 2015, the company agreed to acquire Cliniqa Corporation.
In March 2016, the company acquired Zephyrus Biosciences.
In July 2016, the company acquired Space Import-Export.
In August 2016, company acquired Advanced Cell Diagnostics for $250 million plus an additional $75 million in possible milestone payments.
In September 2017, the company acquired Trevigen.
In January 2018, the company acquired Atlanta Biologicals.
In June 2018, the company agreed to acquire Quad Technologies.
In August 2018, the company acquired Exosome Diagnostics for $250 million plus up to an additional $325 million in milestone payments.
In June 2019, the company acquired B-Mogen.
In April 2021, the company acquired Asuragen for $215 million plus up to an additional $105 million in milestone payments.
In June 2022, the business announced it would acquire Namocell Inc.
In June 2023, Bio-Techne announced it would acquire Lunaphore Technologies SA, the transaction was completed the following month
References
External links
*
{{Finance links
, name = Bio-Techne Corporation
, google = TECH:NASDAQ
, yahoo = TECH
, bloomberg = TECH:US
, reuters = TECH.O
, sec_cik = 842023
1976 establishments in Minnesota
Biotechnology companies of the United States
Companies listed on the Nasdaq
Technology companies established in 1976